Join the American Economic Liberties Project, the National Community Pharmacists Association, Senator Sherrod Brown (D-OH), Congressman Buddy Carter (GA-01), and Federal Trade Commission Chair Lina Khan on Wednesday, June 22 at 1 p.m. ET / 10 a.m. PT for a conversation with pharmacists, doctors, and patients to discuss Pharmacy Benefit Managers (PBMs). We’ll be discussing how the FTC’s new study of PBMs should be encouraging to everyone impacted by PBMs who hope for more transparency as well as the importance of bipartisan solutions from Congress.
PBMs negotiate with drug manufacturers and reimburse pharmacies on behalf of Medicare, Medicaid, and commercial health plans and are intended to reduce prescription drug costs. However, as states, health care providers, and patients have learned, the reality may be more complicated and deserving of scrutiny.
While lawmakers in every state are working to ban PBM practices like spread pricing, claw-backs, and improper pharmacy audits, it is important to tackle this national issue at the federal level as well.
Welcome:
Sarah Miller, Executive Director, American Economic Liberties Project
Remarks:
Senator Sherrod Brown (D-OH)
Congressman Buddy Carter (GA-01)
Panel Discussion: Perspectives on PBM Power
Michele Belcher, President, National Community Pharmacist Association and owner of Grants Pass Pharmacy in Grants Pass, OR
Randy McDonough, Co-Owner, Towncrest Pharmacies in Iowa City, IA and Solon, IA
Dr. Michael Wohlfeiler, Chief Medical Officer, AIDS Healthcare Foundation
Ray Patnaude, Patient Advocate
Moderated by Morgan Harper, Director of Policy & Advocacy, American Economic Liberties Project
Closing Remarks
Lina Khan, Chair, Federal Trade Commission
